Proteomics Platform Target enterprise customers in diagnostics and companion diagnostics by highlighting API's replicable proteomics platform that enables industrial-scale biomarker discovery, appealing to organizations seeking scalable, standards-driven solutions for protein-based diagnostics.

Clinical Development Leverage API's ongoing internal diagnostic programs to position as a partner for co-development or validation studies, offering services from sample processing to informatics that can de-risk and accelerate clinical biomarker programs.

Quality & Process Emphasize extensive quality controls, regimented standard operating procedures, and documented workflows spanning sample collection to processing and data analysis to win customers demanding regulatory-compliant, reproducible research outputs.

Growth Readiness Identify potential fit with mid-sized biotechs and diagnostics developers who need scalable proteomics capabilities, given the company’s small team size but growing revenue and a clear product roadmap, presenting partnerships or service collaborations as low-asset, high-value options.

Market Positioning Differentiate from larger CROs by offering specialized proteomics with accelerated timelines and targeted biomarker discovery, aligning with trends toward precision medicine and companion diagnostics to capture clients seeking niche, expert-driven capabilities.